Navigation Links
Protein ZEB1 promotes breast tumor resistance to radiation therapy
Date:8/4/2014

Twist, Snail, Slug. They may sound like words in a children's nursery rhyme, but they are actually the exotic names given to proteins that can generate cells with stem cell-like properties that have the ability to form diverse types of tissue.

One protein with the even more out-there name of ZEB1 (zinc finger E-box binding homeobox 1), is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a study at The University of Texas MD Anderson Cancer Center in Houston.

Li Ma, Ph.D., an assistant professor of experimental radiation oncology at MD Anderson, reported in this month's issue of Nature Cell Biology that ZEB1 may actually be helping breast tumor cells repair DNA damage caused by radiation treatment by ramping up a first-line of defense known as DNA damage response pathway.

"Radiation therapy causes cell death by inducing DNA ' breaks'," said Ma. "The rationale for treating tumors with radiation without damaging normal tissues is that, compared with normal cells, tumor cells are actively dividing and often have defects in DNA damage repair machinery."

Tumor cells are thus less able to repair DNA damage. But not always. Sometimes the body produces tumor cells resistant to radiation. They are somehow able to "turn on" the DNA damage response apparatus. Until now, the question has always been how?

Ma's team has demonstrated that the wily tumor cell's ability to push the panic button at the last second can be triggered by ZEB1's penchant for launching an operation that generates cancer stem cells.

"The cancer stem cells have been shown to promote radioresistance through activation of the DNA damage response system," said Ma. "Our studies have shown that ZEB1 can induce a process known as epithelial-mesenchymal transition (EMT) which allows certain tumor to acquire cancer stem cell properties including radioresistance."

EMT is one way the body responds to wound healing and it is believed that cancer has found a method for using EMT to promote tumor progression.

ZEB1 achieves this unfortunate result through a complex chain of events that permit a gene known as ATM to stabilize the protein Chk1 that plays an important role in DNA damage response. ZEB1 promotes Chk1's ability to allow tumor radioresistance through deployment of an enzyme called USP7.

The hope is that new approaches to addressing radiation resistance may be developed through gaining better insight into how this signaling pathway keeps tumor cells growing despite being bombarded with toxic radiation treatments.

"Radiation therapy plays a key role in breast cancer management," said Ma. "To overcome the obstacle of radioresistant tumor cells, it is important to identify the critical causes and to develop safe and effective new methods for treatment including the possible use of agents that target ZEB1 and which inhibit CHK1."


'/>"/>
Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Related medicine news :

1. Rare developmental disorder linked to tumor-suppressing protein, Stanford researchers find
2. Breakthrough in understanding of important blood protein
3. U-M researchers find protein that fuels repair of treatment-resistant cancer cells
4. Study Finds Common Blood Protein May Predict Mesothelioma Survival, Reports Surviving Mesothelioma
5. Research may explain how foremost anticancer guardian protein learned to switch sides
6. ProCare Protein Check Tests Surgical Instruments to Verify Effective Cleaning
7. Bariatric Eating Announces Three New Protein Shake Flavors
8. Manipulating key protein in the brain holds potential against obesity and diabetes
9. Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations
10. Researchers unlock the protein puzzle
11. Described novel regulator of a protein inactive in over 50 percent of human tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein ZEB1 promotes breast tumor resistance to radiation therapy
(Date:5/31/2016)... ... ... Spectrum Aquatics has launched a brand new ADA pool lift, the Motion ... user in mind. , “Over the last two years our key customers and designers ... lift is a necessary requirement for certain facilities with specific needs,” said Nabil Khaled, ...
(Date:5/31/2016)... ... , ... Phynd Technologies, Inc. announced recently the signing of three new hospitals: ... Medical Center – Somers Point, NJ. The new clients range in bed size from ... of Phynd’s solution and its interoperability. , Houston Methodist is a leading academic medical ...
(Date:5/31/2016)... ... May 31, 2016 , ... MinerEye today announced ... Security Infrastructure Protection report by Gartner1 Inc. , Each year, Gartner identifies new ... evaluating these innovative vendors and their products and services. , According to Gartner, ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... to apply information technology solutions to the healthcare industry, The University of Scranton ... program offers an accelerated path to a career in rapidly growing field of ...
(Date:5/30/2016)... ... May 30, 2016 , ... As the CDC relaxes its stance on ... efforts to keep their households lice free. , According to a May 26 ... that keep kids in the classroom despite the fact that they may be harboring ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... 30, 2016 The global  ... 7.3 billion by 2024, according to a new ... natality rate, the growing malnutrition coupled with the ... gastro-intestinal tract diseases are expected to boost the ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ...
(Date:5/27/2016)... study highlights the necessity of health literacy within the technology advancement of diagnostic imaging. According ... , a majority of oncology patients undergo imaging screenings without understanding the nuanced risks ... ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... 27, 2016 Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... at two upcoming investor conferences: SeeThru Equity MicroCap ... New York City , NY When: ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, 109 ...
Breaking Medicine Technology: